Leukocyte Telomere Length Is Unrelated to Cognitive Performance Among Non-Demented and Demented Persons: An Examination of Long Life Family Study Participants
Abstract:Objective:
Leukocyte telomere length (LTL) is a widely hypothesized biomarker of biological aging. Persons with shorter LTL may have a greater likelihood of developing dementia. We investigate whether LTL is associated with cognitive function, differently for individuals without cognitive impairment versus individuals with dementia or incipient dementia.
Method:
Enrolled subjects belong to the Long Life Family Study (LLFS), a multi-generational cohort study, where enrollment was predicat… Show more
“…The flow chart of the selection process was exhibited in Figure 1. In total, 25 articles met our inclusion criteria 3–19,22–29. Among these studies, 22 articles were on the study of TL, 1 article was on the study of telomerase activity, and the remaining 2 articles focused on TL and telomerase activity.…”
Section: Resultsmentioning
confidence: 99%
“…In total, 25 articles met our inclusion criteria. [3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][22][23][24][25][26][27][28][29] Among these studies, 22 articles were on the study of TL, 1 article was on the study of telomerase activity, and the remaining 2 articles focused on TL and telomerase activity. Besides, Thomas et al 19 studied the TL of white blood cells, buccal cells, and brain tissue in AD patients and the matched controls, and the AD patients were divided into young and old AD groups, respectively.…”
Section: Research Optionsmentioning
confidence: 99%
“…The stability of the telomere-telomerase system is closely related to AD. Studies have shown that telomere shortening has a close relationship with the increasing risk of AD, [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17] but some studies hold the opposite view. 18 Studies have found that the maintenance of telomeres in AD patients is significantly different among different sampled tissues.…”
Background:
Alzheimer disease (AD) is the most common neurodegenerative disease of the central nervous system. The stability of the telomere-telomerase system is closely related to AD. A previous meta-analysis indicated that AD patients had shorter telomere length (TL) than control subjects. However, there are no consistent telomerase activity findings in AD patients, and the published telomerase studies were not meta-analyzed yet.
Methods:
We searched all the related studies that probed into TL and/or telomerase activity in AD patients based on PubMed and Embase database from the establishment to September 2020. The Chinese National Knowledge Infrastructure, Wanfang and China Science and Technology Journal Database were also utilized. The quality of the included studies was evaluated by using Newcastle-Ottawa Scale. All the statistical analyses of this meta-analysis were performed using Stata version 15.0.
Results:
Analyzing 30 TL data from 2248 AD patients and 4865 controls, AD patients had a significantly shorter TL than the controls, with a standardized mean difference of −0.70 (confidence interval: −0.95 to −0.46; P<0.05). The meta-analysis included 3 primary studies and did not find a significant difference in the telomerase activity between 233 AD patients and 132 controls, but AD patients had a trend of increased telomerase activity compared with controls (standardized mean difference: 0.47; confidence interval: −0.29 to 1.23; P>0.05).
Conclusion:
Our results showed that compared with the control group, the AD group had a shorter TL and may have higher telomerase activity.
“…The flow chart of the selection process was exhibited in Figure 1. In total, 25 articles met our inclusion criteria 3–19,22–29. Among these studies, 22 articles were on the study of TL, 1 article was on the study of telomerase activity, and the remaining 2 articles focused on TL and telomerase activity.…”
Section: Resultsmentioning
confidence: 99%
“…In total, 25 articles met our inclusion criteria. [3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][22][23][24][25][26][27][28][29] Among these studies, 22 articles were on the study of TL, 1 article was on the study of telomerase activity, and the remaining 2 articles focused on TL and telomerase activity. Besides, Thomas et al 19 studied the TL of white blood cells, buccal cells, and brain tissue in AD patients and the matched controls, and the AD patients were divided into young and old AD groups, respectively.…”
Section: Research Optionsmentioning
confidence: 99%
“…The stability of the telomere-telomerase system is closely related to AD. Studies have shown that telomere shortening has a close relationship with the increasing risk of AD, [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17] but some studies hold the opposite view. 18 Studies have found that the maintenance of telomeres in AD patients is significantly different among different sampled tissues.…”
Background:
Alzheimer disease (AD) is the most common neurodegenerative disease of the central nervous system. The stability of the telomere-telomerase system is closely related to AD. A previous meta-analysis indicated that AD patients had shorter telomere length (TL) than control subjects. However, there are no consistent telomerase activity findings in AD patients, and the published telomerase studies were not meta-analyzed yet.
Methods:
We searched all the related studies that probed into TL and/or telomerase activity in AD patients based on PubMed and Embase database from the establishment to September 2020. The Chinese National Knowledge Infrastructure, Wanfang and China Science and Technology Journal Database were also utilized. The quality of the included studies was evaluated by using Newcastle-Ottawa Scale. All the statistical analyses of this meta-analysis were performed using Stata version 15.0.
Results:
Analyzing 30 TL data from 2248 AD patients and 4865 controls, AD patients had a significantly shorter TL than the controls, with a standardized mean difference of −0.70 (confidence interval: −0.95 to −0.46; P<0.05). The meta-analysis included 3 primary studies and did not find a significant difference in the telomerase activity between 233 AD patients and 132 controls, but AD patients had a trend of increased telomerase activity compared with controls (standardized mean difference: 0.47; confidence interval: −0.29 to 1.23; P>0.05).
Conclusion:
Our results showed that compared with the control group, the AD group had a shorter TL and may have higher telomerase activity.
“…One study has reported no correlation between telomere length and cognitive performance among non-demented and demented people in long-life family study participants. 36 It has also been reported that telomere length is not predictive of dementia or MCI conversion in the oldest old. 37 One study has shown that both longer telomere length and shorter telomere length are associated with an increased risk of AD in the Rotterdam study.…”
Section: Telomere Length In Neurodedenerative Disordersmentioning
Telomeres are located at the end of chromosomes. They are known to protect chromosomes and prevent cellular senescence. Telomere length shortening has been considered an important marker of aging. Many studies have reported this concept in connection with neurodegenerative disorders. Considering the role of telomeres, it seems that longer telomeres are beneficial while shorter telomeres are detrimental in preventing neurodegenerative disorders. However, several studies have shown that people with longer telomeres might also be vulnerable to neurodegenerative disorders. Before these conflicting results can be explained through large-scale longitudinal clinical studies on the role of telomere length in neurodegenerative disorders, it would be beneficial to simultaneously review these opposing results. Understanding these conflicting results might help us plan future studies to reveal the role of telomere length in neurodegenerative disorders. In this review, these contradictory findings are thoroughly discussed, with the aim to better understand the role of telomere length in neurodegenerative disorders.
“…Nonetheless, one large prospective study comprising n = 1,961 Dutch participants reported an U-shaped association, with higher risks of Alzheimer’s disease in the lowest and highest tertiles of TL relative to the middle tertile 28 . While, another cross sectional study comprising n = 2,210 participants demonstrating exceptional longevity from USA and Denmark reported null associations between leucocyte TL and cognitive performance in both cognitively unimpaired and demented sub-groups 29 .…”
Socio-economic status (SES) and biological aging are risk factors for dementia, including Alzheimer’s disease, however, it is less clear if the associations with SES vary sufficiently across different biological age strata. We used data from 331,066 UK Biobank participants aged 38–73 with mean follow-up of 12 years to examine if associations between SES (assessed by educational attainment, employment status and household income) and dementia and Alzheimer’s disease are modified by biological age (assessed by leucocyte telomere length: LTL). Diagnosis of events was ascertained through hospital admissions data. Cox regressions were used to estimate hazard ratios [HRs]. A consistent dose–response relationship was found, with participants in low SES and shorter LTL strata (double-exposed group) reporting 3.28 (95% confidence interval [CI] 2.57–4.20) and 3.44 (95% CI 2.35–5.04) times higher risks of incident dementia and Alzheimer’s disease respectively, compared to those of high SES and longer LTL (least-exposed group). Of interest is a synergistic interaction between SES and LTL to increase risk of dementia (RERI 0.57, 95% CI 0.07–1.06) and Alzheimer’s disease (RERI 0.79, 95% CI 0.02–1.56). Our findings that SES and biological age (LTL) are synergistic risk factors of dementia and Alzheimer’s disease may suggest the need to target interventions among vulnerable sub-groups.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.